By Connor Hart
Delta Air Lines lowered its first-quarter outlook, citing reduced consumer and corporate confidence amid economic uncertainty. The airline now expects adjusted per-share earnings of 30 cents to 50 cents and for revenue to rise 3% to 4% from a year ago, compared with a prior outlook for adjusted per-share earnings of 70 cents to $1 and for revenue to rise 7% to 9%. Delta said that domestic travel is most heavily affected. Shares fall 11%, to $44.70, in after-hours trading.
Oracle's fiscal third-quarter results missed expectations, though the cloud-services offered an upbeat sales outlook as it aims to double its data center capacity this year. The company reported adjusted earnings of $1.47 a share on revenue of $14.13 billion, missing analyst forecasts for adjusted earnings of $1.49 a share on revenue of $14.38 billion. For the current quarter, Oracle expects revenue to grow 9% to 11%, with total cloud revenue jumping between 24% and 28%. Shares fall 3.4%, to $143.77, in postmarket trading.
LifeMD's fourth-quarter financial results topped analyst expectations. The telehealth company posted a per-share loss of 2 cents, ahead of the 7-cent loss that analysts modeled. Revenue of $64.3 million topped analyst views for $57.5 million. The company guided for sales of $265 million to $275 million in 2025, above the $258 million that analysts were looking for. Shares jump 25%, to $5.35, in after-hours trading.
Tenon Medical received notice of two approvals from the European patent office. The medical-device maker after the bell said two additional patents related to its Catamaran Sacroiliac Joint Fixation Device have been approved for grant of a European patent within the European Community. Shares rise 44%, to $1.80, in postmarket trading.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
March 10, 2025 19:31 ET (23:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.